Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes

Yuda Zong, Junyu Guo, Tianyi Ke, Aaron M. Mohs, Dennis L. Parker, Zheng Rong Lu

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The purpose of this study is to investigate how the structures of polydisulfide Gd(III) complexes affect their pharmacokinetics and in vivo contrast enhancement as biodegradable macromolecular MRI contrast agents. A negatively charged polydisulfide Gd(III) complex, (Gd-DTPA)-cystine copolymers (GDCP), and a neutral agent, (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), with different molecular weights were prepared and characterized. The MRI contrast enhancement of the agents was studied in mice. Neutral GDCEP showed more rapid degradation than negatively charged GDCP in the blood plasma. Consequently, GDCP resulted in more significant and prolonged contrast enhancement in the blood pool and liver than GDCEP. The size of GDCEP did not significantly affect its in vivo contrast enhancement due to rapid degradation and clearance from the blood circulation. The increase in the molecular weight of GDCP resulted in prolonged in vivo contrast enhancement in the blood pool. The structural modification of polydisulfide Gd(III) complexes resulted in biodegradable macromolecular MRI contrast agents with different degradability and in vivo contrast enhancement.

Original languageEnglish (US)
Pages (from-to)350-356
Number of pages7
JournalJournal of Controlled Release
Volume112
Issue number3
DOIs
StatePublished - May 30 2006

Fingerprint

Pharmacokinetics
Contrast Media
Molecular Weight
Blood Circulation
gadolinium-DTPA cystine copolymer
gadolinium-DTPA cystine diethyl ester copolymer
Liver

Keywords

  • Biodegradable macromolecular contrast agents
  • Blood pool contrast agents
  • Gadolinium
  • MRI
  • Polydisulfide

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes. / Zong, Yuda; Guo, Junyu; Ke, Tianyi; Mohs, Aaron M.; Parker, Dennis L.; Lu, Zheng Rong.

In: Journal of Controlled Release, Vol. 112, No. 3, 30.05.2006, p. 350-356.

Research output: Contribution to journalArticle

Zong, Yuda ; Guo, Junyu ; Ke, Tianyi ; Mohs, Aaron M. ; Parker, Dennis L. ; Lu, Zheng Rong. / Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes. In: Journal of Controlled Release. 2006 ; Vol. 112, No. 3. pp. 350-356.
@article{dc786b670ace4734b906e0806db18441,
title = "Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes",
abstract = "The purpose of this study is to investigate how the structures of polydisulfide Gd(III) complexes affect their pharmacokinetics and in vivo contrast enhancement as biodegradable macromolecular MRI contrast agents. A negatively charged polydisulfide Gd(III) complex, (Gd-DTPA)-cystine copolymers (GDCP), and a neutral agent, (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), with different molecular weights were prepared and characterized. The MRI contrast enhancement of the agents was studied in mice. Neutral GDCEP showed more rapid degradation than negatively charged GDCP in the blood plasma. Consequently, GDCP resulted in more significant and prolonged contrast enhancement in the blood pool and liver than GDCEP. The size of GDCEP did not significantly affect its in vivo contrast enhancement due to rapid degradation and clearance from the blood circulation. The increase in the molecular weight of GDCP resulted in prolonged in vivo contrast enhancement in the blood pool. The structural modification of polydisulfide Gd(III) complexes resulted in biodegradable macromolecular MRI contrast agents with different degradability and in vivo contrast enhancement.",
keywords = "Biodegradable macromolecular contrast agents, Blood pool contrast agents, Gadolinium, MRI, Polydisulfide",
author = "Yuda Zong and Junyu Guo and Tianyi Ke and Mohs, {Aaron M.} and Parker, {Dennis L.} and Lu, {Zheng Rong}",
year = "2006",
month = "5",
day = "30",
doi = "10.1016/j.jconrel.2006.03.006",
language = "English (US)",
volume = "112",
pages = "350--356",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes

AU - Zong, Yuda

AU - Guo, Junyu

AU - Ke, Tianyi

AU - Mohs, Aaron M.

AU - Parker, Dennis L.

AU - Lu, Zheng Rong

PY - 2006/5/30

Y1 - 2006/5/30

N2 - The purpose of this study is to investigate how the structures of polydisulfide Gd(III) complexes affect their pharmacokinetics and in vivo contrast enhancement as biodegradable macromolecular MRI contrast agents. A negatively charged polydisulfide Gd(III) complex, (Gd-DTPA)-cystine copolymers (GDCP), and a neutral agent, (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), with different molecular weights were prepared and characterized. The MRI contrast enhancement of the agents was studied in mice. Neutral GDCEP showed more rapid degradation than negatively charged GDCP in the blood plasma. Consequently, GDCP resulted in more significant and prolonged contrast enhancement in the blood pool and liver than GDCEP. The size of GDCEP did not significantly affect its in vivo contrast enhancement due to rapid degradation and clearance from the blood circulation. The increase in the molecular weight of GDCP resulted in prolonged in vivo contrast enhancement in the blood pool. The structural modification of polydisulfide Gd(III) complexes resulted in biodegradable macromolecular MRI contrast agents with different degradability and in vivo contrast enhancement.

AB - The purpose of this study is to investigate how the structures of polydisulfide Gd(III) complexes affect their pharmacokinetics and in vivo contrast enhancement as biodegradable macromolecular MRI contrast agents. A negatively charged polydisulfide Gd(III) complex, (Gd-DTPA)-cystine copolymers (GDCP), and a neutral agent, (Gd-DTPA)-cystine diethyl ester copolymers (GDCEP), with different molecular weights were prepared and characterized. The MRI contrast enhancement of the agents was studied in mice. Neutral GDCEP showed more rapid degradation than negatively charged GDCP in the blood plasma. Consequently, GDCP resulted in more significant and prolonged contrast enhancement in the blood pool and liver than GDCEP. The size of GDCEP did not significantly affect its in vivo contrast enhancement due to rapid degradation and clearance from the blood circulation. The increase in the molecular weight of GDCP resulted in prolonged in vivo contrast enhancement in the blood pool. The structural modification of polydisulfide Gd(III) complexes resulted in biodegradable macromolecular MRI contrast agents with different degradability and in vivo contrast enhancement.

KW - Biodegradable macromolecular contrast agents

KW - Blood pool contrast agents

KW - Gadolinium

KW - MRI

KW - Polydisulfide

UR - http://www.scopus.com/inward/record.url?scp=33646689144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646689144&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2006.03.006

DO - 10.1016/j.jconrel.2006.03.006

M3 - Article

C2 - 16631270

AN - SCOPUS:33646689144

VL - 112

SP - 350

EP - 356

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 3

ER -